Bioplus Acquisition (BIOSU) Stock Price, News & Analysis

Name: Bioplus Acquisition Corp. (BIOSU) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

BIOSU

Company Description

This page collects what Stock Titan holds for BIOSU, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

23.6M

Shares outstanding

Latest News

View All

October 4, 2023

-0.18%

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate

acquisition

December 6, 2021

+0.20%

BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering

IPO offering acquisition

December 2, 2021

—

BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering

IPO offering acquisition

Bioplus Acquisition has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all BIOSU news →

SEC Filings

View All

No SEC filings available for BIOSU.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months